A source-linked medicines answer is useful only when the link supports the statement you intend to use. Start with the exact product, open the relevant emc document and compare its wording with the explanation. Keep the document's qualifications visible. A general answer must not turn missing clinical information into an assumed fact.
This guide is published by iatroX and explains its own medicines-reference workflow. There is a documented connection between the services. Datapharm's partnership announcement, publicly available and checked on 20 September 2026, confirms the use of emc medicines information within iatroX's clinical-reference workflow. That establishes a content relationship. It does not establish that every generated response is correct or that the application has regulatory approval for every possible use.
Know which document you have opened
emc's own explanation, checked on the review date, distinguishes information for healthcare professionals from patient information. A Summary of Product Characteristics, or SmPC, and a patient information leaflet have different purposes. Similar product names do not make the documents interchangeable.
Before reading an answer, establish the medicine, formulation and manufacturer or authorisation-holder information relevant to the question. Check that the linked page is the intended document rather than a search result, an unrelated product or a patient leaflet being presented as a professional monograph.
The aim is not to make every lookup laborious. It is to avoid verifying a statement against the wrong object. Reading the correct section of the wrong product document does not resolve the original question.
An original source-checking exercise
Imagine a fictional clinician preparing to explain why a medicine's patient leaflet and professional product information use different levels of detail about an adverse effect. The clinician is not asking whether a real patient should start, stop or alter treatment. The educational question is how the two documents relate and what additional information would be required for an individual decision.
A useful prompt might be: "Explain the difference between the patient leaflet and professional product information for this medicines question. Identify the relevant source and distinguish what the document states from what would require patient-specific assessment." This is a proposed prompt, not a transcript of a completed Ask-iatroX session.
Choose one consequential statement in the resulting explanation and follow its source. Record the product, document type, relevant heading and the exact qualification that affects interpretation. Then ask whether the explanation preserved that qualification or silently broadened it.
For instance, a statement about a studied population should not become an assertion about every patient. A caution should not be rewritten as an absolute contraindication, and an absence of information should not become evidence of safety. These are examples of interpretation errors to look for, not allegations that the current product made them.
Use the SmPC's structure to find the right question
The SmPC organises clinical particulars into labelled sections. Its headings help distinguish therapeutic use, contraindications, warnings, interactions, pregnancy and lactation, and adverse effects. emc's glossary explains the document and its terminology. Check the relevant heading rather than assume that the first mention of a word contains the whole answer.
The section you need depends on the question. An interaction enquiry is not settled by reading only the general indication. A question about a product's constituents may require a different part of the document from a question about reported adverse effects. A clinical decision can require more than one section and a specialist source beyond the SmPC.
This article deliberately supplies no clinical doses or product-specific treatment instructions. Its purpose is to make the verification process usable without turning an illustrative exercise into a prescribing shortcut.
A compact evidence record
Use the following original record when an answer contains a claim important enough to check carefully. It can be kept as a learning note without including identifiable patient material.
| Field | What to record |
|---|---|
| Question | The precise uncertainty, including whether it is general learning or a clinical enquiry |
| Product | The actual product and formulation addressed by the source |
| Source | Document type, relevant heading, link and date checked |
| Supported statement | What the document actually establishes, in your own words |
| Qualification | Population, condition or limitation that changes the interpretation |
| Remaining uncertainty | What the document or question does not establish |
| Next step | A further source check or appropriate professional clarification |
The most valuable field is often remaining uncertainty. Without it, a note can look complete simply because every box contains text. A useful record makes an unresolved issue easier to recognise later, not easier to forget.
Separate source status from answer status
Datapharm describes the emc information in the partnership as regulator-approved medicines information. That description concerns the underlying product information. The subsequent explanation is another step, requiring accurate retrieval, interpretation and presentation. A source's status cannot be transferred automatically to every sentence generated around it.
iatroX's published methodology, checked on 20 September 2026, describes source retrieval and citation-grounded synthesis with checks and uncertainty handling. These are design features. A reader should still be able to trace a claim to the material supporting it and identify what remains outside the source.
This is not a reason to reject explanatory tools. It is the condition that makes their convenience meaningful: the explanation should bring the clinician closer to the evidence rather than replace it with an inaccessible assertion.
When another resource or professional is needed
An SmPC cannot answer every practical medicines question. A specialist interaction, injectable compatibility, pregnancy or lactation enquiry may require a dedicated reference and appropriate medicines-information support. The exact resource depends on the question, not on which search result appears first.
Likewise, the clinical record and responsible team establish what has actually been prescribed, supplied and agreed. Neither emc nor a generated explanation can infer an undocumented change in a patient's plan. Keep source interpretation separate from reconciliation of real-world records.
Make the learning specific
After checking the source, write one sentence describing what you had misunderstood. Perhaps you confused a caution with a prohibition, or treated two formulations as equivalent. That sentence can guide a relevant question or Tutor discussion instead of another broad medicine search.
As specified in September 2026, Ask-iatroX and free question access remain free; structured learning tools have their separate published subscription. A one-off verification may need nothing more than the source. A repeated misconception may justify focused learning. The decision follows the gap, not the desire to collect another record.
Frequently asked questions
Does iatroX have a documented relationship with emc?
Yes. Datapharm's public partnership announcement confirms emc medicines information within iatroX's clinical-reference workflow; it was checked on 20 September 2026.
Does a regulator-approved source make every AI answer regulator-approved?
No. The underlying product document and the application's generated explanation are different objects, and the latter still requires appropriate interpretation and verification.
What should I do when the cited document does not answer the question?
Keep the uncertainty explicit and use the appropriate specialist source or professional advice route. Do not treat missing information as a favourable answer.